CERBERUS

Welcome to the Brand page for “CERBERUS”, which is offered here for Pharmaceutical preparations for use in oncology; pharmaceutical preparations and substances for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines;medical diagnosis and treatment of cancer; providing information in the field of cancer diagnosis and treatment; providing healthcare and medical information;medical and pharmaceutical research services in the field of cancer; medical and pharmaceutical research services; pharmaceutical research and development in the field of cancer; pharmaceutical research and development; research, development, and testing services in the fields of pharmaceutical and biotechnology products; drug discovery, research, and development in the pharmaceutical and biotechnology fields;.

Its status is currently believed to be active. Its class is unavailable. “CERBERUS” is believed to be currently owned by “Harpoon Therapeutics, Inc.”